help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, A.
Right arrow Articles by Clemmons, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, A.
Right arrow Articles by Clemmons, D. R.

Endocrinology, Vol 136, 2470-2476, Copyright © 1995 by Endocrine Society

ARTICLES

Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells

A Parker, A Gockerman, WH Busby and DR Clemmons
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill 27599, USA.

Smooth muscle cells (SMC) secrete insulin-like growth factor (IGF)- binding protein-4 (IGFBP-4) and an IGFBP-4 protease. The purpose of this study was to determine the characteristics of this IGFBP-4 protease and to compare its inhibitor profile to those of IGFBP-5 and IGFBP-2 proteases, which are also present in SMC-conditioned medium. Cultured SMC were exposed to serum-free medium for periods of 24-72 h, and the amount of proteolytic activity in the conditioned medium was assessed by its capacity to degrade pure IGFBP-4. Minimal activity (e.g. < 20% of IGFBP-4 degraded in 24 h at 37 C) was present in conditioned medium unless IGF-I or IGF-II was added. This resulted in more than 60% of the intact IGFBP-4 being degraded in 14 h. The activity was a calcium-dependent serine protease and was inhibited by EDTA or 3,4-dicloroisocoumarin. Calcium, but not zinc, could restore proteolytic activity. Heparin alone inhibited IGFBP-4 proteolysis by more than 60%. When heparin cofactor-II and antithrombin-III (AT-III) were added alone, they each had an effect. The combination of heparin plus AT-III was no more active than heparin alone, but the combination of heparin cofactor-II and heparin resulted in near complete inhibition. Peptides that contained the active sites of AT-III or alpha 1-antichymotrypsin were potent inhibitors of the IGFBP-4 protease. The medium also contained proteolytic activities for IGFBP-2 and IGFBP-5. Comparison of the inhibitor profiles for the IGFBP-4 and IGFBP-5 proteolytic activities revealed major differences, but the IGFBP-2 proteolytic activity was very similar to that of the IGFBP-4 protease. IGFBP-4 zymography showed a band with a molecular mass estimate of 48 kilodaltons. In contrast, when IGFBP-2 was used as the substrate, a single band at 36 kilodaltons was visualized. These data taken together with the protease inhibitor results suggest that the IGFBP-2, IGFBP-4, and IGFBP-5 proteases are members of a similar family of calcium- dependent serine proteases, but they are distinct proteases. As IGFBP-4 is a potent inhibitor of IGF action, and the activity of this protease is regulated by IGF exposure, the protease represents a novel system for regulating the actions of IGF-I in this cell type.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
Y. Radhakrishnan, L. A. Maile, Y. Ling, L. M. Graves, and D. R. Clemmons
Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells
J. Biol. Chem., June 13, 2008; 283(24): 16320 - 16331.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. C. Nichols, W. H. Busby Jr., E. Merricks, J. Sipos, M. Rowland, K. Sitko, and D. R. Clemmons
Protease-Resistant Insulin-Like Growth Factor (IGF)-Binding Protein-4 Inhibits IGF-I Actions and Neointimal Expansion in a Porcine Model of Neointimal Hyperplasia
Endocrinology, October 1, 2007; 148(10): 5002 - 5010.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Lieskovska, Y. Ling, J. Badley-Clarke, and D. R. Clemmons
The Role of Src Kinase in Insulin-like Growth Factor-dependent Mitogenic Signaling in Vascular Smooth Muscle Cells
J. Biol. Chem., September 1, 2006; 281(35): 25041 - 25053.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Kwon, Y. Ling, L. A. Maile, J. Badley-Clark, and D. R. Clemmons
Recruitment of the Tyrosine Phosphatase Src Homology 2 Domain Tyrosine Phosphatase-2 to the p85 Subunit of Phosphatidylinositol-3 (PI-3) Kinase Is Required for Insulin-Like Growth Factor-I-Dependent PI-3 Kinase Activation in Smooth Muscle Cells
Endocrinology, March 1, 2006; 147(3): 1458 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
Y. Ling, L. A. Maile, J. Lieskovska, J. Badley-Clarke, and D. R. Clemmons
Role of SHPS-1 in the Regulation of Insulin-like Growth Factor I-stimulated Shc and Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells
Mol. Biol. Cell, July 1, 2005; 16(7): 3353 - 3364.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Ling, L. A. Maile, J. Badley-Clarke, and D. R. Clemmons
DOK1 Mediates SHP-2 Binding to the {alpha}V{beta}3 Integrin and Thereby Regulates Insulin-like Growth Factor I Signaling in Cultured Vascular Smooth Muscle Cells
J. Biol. Chem., February 4, 2005; 280(5): 3151 - 3158.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Ling, L. A. Maile, and D. R. Clemmons
Tyrosine Phosphorylation of the {beta}3-Subunit of the {alpha}V{beta}3 Integrin Is Required for Membrane Association of the Tyrosine Phosphatase SHP-2 and Its Further Recruitment to the Insulin-Like Growth Factor I Receptor
Mol. Endocrinol., September 1, 2003; 17(9): 1824 - 1833.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. M. Firth and R. C. Baxter
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Endocr. Rev., December 1, 2002; 23(6): 824 - 854.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Hourvitz, A. Kuwahara, J. D. Hennebold, A. B. Tavares, H. Negishi, T. H. Lee, G. F. Erickson, and E. Y. Adashi
The Regulated Expression of the Pregnancy-Associated Plasma Protein-A in the Rodent Ovary: A Proposed Role in the Development of Dominant Follicles and of Corpora Lutea
Endocrinology, May 1, 2002; 143(5): 1833 - 1844.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B.-K. Chen, M. T. Overgaard, L. K. Bale, Z. T. Resch, M. Christiansen, C. Oxvig, and C. A. Conover
Molecular Regulation of the IGF-Binding Protein-4 Protease System in Human Fibroblasts: Identification of a Novel Inducible Inhibitor
Endocrinology, April 1, 2002; 143(4): 1199 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Shalamanova, B. Kubler, J.-G. Scharf, and T. Braulke
MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1221 - E1229.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. P. Smith, A. Kamyar, W. Niu, J. Wang, B. Cercek, S. D. Chernausek, and J. A. Fagin
IGF-Binding Protein-4 Expression and IGF-Binding Protein-4 Protease Activity Are Regulated Coordinately in Smooth Muscle During Postnatal Development and After Vascular Injury
Endocrinology, October 1, 2001; 142(10): 4420 - 4427.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Bayes-Genis, R. S. Schwartz, D. A. Lewis, M. T. Overgaard, M. Christiansen, C. Oxvig, K. Ashai, D. R. Holmes Jr, and C. A. Conover
Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty
Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 335 - 341.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle and B. Teng
Regulation of IGFBP-4 levels in human intestinal muscle by an IGF-I-activated, confluence-dependent protease
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G975 - G982.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. R. SCHNEIDER, H. LAHM, M. WU, A. HOEFLICH, and E. WOLF
Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins
FASEB J, April 1, 2000; 14(5): 629 - 640.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Anwar, A. A. Zahid, L. Phillips, and P. Delafontaine
Insulin-Like Growth Factor Binding Protein-4 Expression Is Decreased by Angiotensin II and Thrombin in Rat Aortic Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 370 - 376.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. B. Lawrence, C. Oxvig, M. T. Overgaard, L. Sottrup-Jensen, G. J. Gleich, L. G. Hays, J. R. Yates III, and C. A. Conover
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A
PNAS, March 16, 1999; 96(6): 3149 - 3153.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen
Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. Duan and D. R. Clemmons
Differential Expression and Biological Effects of Insulin-like Growth Factor-binding Protein-4 and -5 in Vascular Smooth Muscle Cells
J. Biol. Chem., July 3, 1998; 273(27): 16836 - 16842.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Wang, W. Niu, D. P. Witte, S. D. Chernausek, Y. E. Nikiforov, T. L. Clemens, B. Sharifi, A. R. Strauch, and J. A. Fagin
Overexpression of Insulin-Like Growth Factor-Binding Protein-4 (IGFBP-4) in Smooth Muscle Cells of Transgenic Mice through a Smooth Muscle {alpha}-Actin-IGFBP-4 Fusion Gene Induces Smooth Muscle Hypoplasia
Endocrinology, May 1, 1998; 139(5): 2605 - 2614.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Kubler, S. Cowell, J. Zapf, and T. Braulke
Proteolysis of Insulin-Like Growth Factor Binding Proteins by a Novel 50-Kilodalton Metalloproteinase in Human Pregnancy Serum
Endocrinology, April 1, 1998; 139(4): 1556 - 1563.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Zheng, J. B. Clarke, W. H. Busby, C. Duan, and D. R. Clemmons
Insulin-Like Growth Factor-Binding Protein-5 Is Cleaved by Physiological Concentrations of Thrombin
Endocrinology, April 1, 1998; 139(4): 1708 - 1714.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. G. Armstrong, G. Baxter, C. G. Gutierrez, C. O. Hogg, A. L. Glazyrin, B. K. Campbell, T. A. Bramley, and R. Webb
Insulin-Like Growth Factor Binding Protein -2 and -4 Messenger Ribonucleic Acid Expression in Bovine Ovarian Follicles: Effect of Gonadotropins and Developmental Status
Endocrinology, April 1, 1998; 139(4): 2146 - 2154.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. A. Jacot and D. R. Clemmons
Effect of Glucose on Insulin-Like Growth Factor Binding Protein-4 Proteolysis
Endocrinology, January 1, 1998; 139(1): 44 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. Rajaram, D. J. Baylink, and S. Mohan
Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions
Endocr. Rev., December 1, 1997; 18(6): 801 - 831.
[Abstract] [Full Text]

Home page
 Cardiovasc ResHome page
P. Delafontaine and L. Ku
Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells
Cardiovasc Res, January 1, 1997; 33(1): 216 - 222.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Duan, S. B. Hawes, T. Prevette, and D. R. Clemmons
Insulin-like Growth Factor-I (IGF-I) Regulates IGF-binding Protein-5 Synthesis through Transcriptional Activation of the Gene in Aortic Smooth Muscle Cells
J. Biol. Chem., February 23, 1996; 271(8): 4280 - 4288.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society